TD Capital Management’s Medtronic MDT Stock Holding History

TD Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.8K	Buy	690 +125	+22%	+$12K	0.01%	220
2025 Q4	$54.3K	Buy	565 +410	+265%	+$39.8K	﹤0.01%	224
2025 Q3	$14.8K	Hold	155	–	–	﹤0.01%	373
2025 Q2	$13.5K	Buy	+155	New	+$13.1K	﹤0.01%	377
2023 Q2	–	Sell	-78	Closed	-$6.26K	–	419
2023 Q1	$6.26K	Buy	78 +1	+1%	+$82	﹤0.01%	304
2022 Q4	$5.98K	Buy	+77	New	+$6.24K	﹤0.01%	285

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TD Capital Management's MDT Position: Q1 2026 in Review

TD Capital Management increased its Medtronic (MDT) stake by 22% in Q1 2026, buying an estimated $12K and bringing the position to 690 shares worth $59.8K. The position accounts for 0.01% of the portfolio, ranked #220.

TD Capital Management first reported a position in MDT in Q4 2022 and has held it in 6 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

TD Capital Management held 690 shares of Medtronic worth $59.8K as of Q1 2026.
TD Capital Management bought 125 Medtronic shares in Q1 2026, an estimated $12K.
Medtronic made up 0.01% of TD Capital Management's portfolio in Q1 2026, its #220 holding.
TD Capital Management first reported a position in Medtronic in Q4 2022 and has held it in 6 quarters since.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.